A detailed history of Met Life Investment Management, LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,964 shares of MGTX stock, worth $226,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,964
Previous 18,263 69.54%
Holding current value
$226,037
Previous $76,000 147.37%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$4.03 - $7.1 $51,185 - $90,177
12,701 Added 69.54%
30,964 $188,000
Q3 2024

Nov 13, 2024

SELL
$3.88 - $5.23 $23,318 - $31,432
-6,010 Reduced 24.76%
18,263 $76,000
Q2 2024

Aug 13, 2024

BUY
$4.21 - $5.81 $64,236 - $88,648
15,258 Added 169.25%
24,273 $102,000
Q1 2024

May 14, 2024

BUY
$5.78 - $7.33 $52,106 - $66,079
9,015 New
9,015 $54,000
Q2 2023

Apr 29, 2024

BUY
$5.19 - $8.07 $82,884 - $128,877
15,970 New
15,970 $107,000
Q2 2023

Aug 10, 2023

BUY
$5.19 - $8.07 $82,884 - $128,877
15,970 New
15,970 $107,000
Q1 2023

May 09, 2024

BUY
$5.04 - $8.6 $80,488 - $137,342
15,970 New
15,970 $82.6 Million
Q4 2022

Jun 14, 2023

BUY
$5.8 - $8.98 $92,626 - $143,410
15,970 New
15,970 $104 Million
Q3 2022

Jun 14, 2023

BUY
$7.55 - $11.25 $120,573 - $179,662
15,970 New
15,970 $134 Million
Q2 2022

Jun 20, 2023

BUY
$6.8 - $14.23 $108,596 - $227,253
15,970 New
15,970 $121 Million
Q1 2022

May 10, 2024

BUY
$13.42 - $23.38 $214,317 - $373,378
15,970 New
15,970 $221,000
Q1 2022

Jun 20, 2023

BUY
$13.42 - $23.38 $214,317 - $373,378
15,970 New
15,970 $221 Million
Q4 2021

Jun 21, 2023

BUY
$12.78 - $23.74 $133,359 - $247,726
10,435 New
10,435 $248 Million
Q3 2021

Jun 21, 2023

BUY
$11.73 - $16.08 $122,402 - $167,794
10,435 New
10,435 $138 Million
Q1 2021

May 17, 2024

BUY
$13.84 - $17.8 $19,652 - $25,276
1,420 Added 15.75%
10,435 $150,000
Q1 2021

Jun 26, 2023

BUY
$13.84 - $17.8 $144,420 - $185,743
10,435 New
10,435 $151 Million
Q4 2020

Jun 22, 2023

BUY
$12.4 - $17.6 $126,690 - $179,819
10,217 New
10,217 $155 Million
Q3 2020

Jun 26, 2023

BUY
$11.59 - $14.93 $118,415 - $152,539
10,217 New
10,217 $135 Million
Q2 2020

May 24, 2024

BUY
$11.79 - $15.97 $14,171 - $19,195
1,202 Added 13.33%
10,217 $128 Million
Q2 2020

Jun 26, 2023

BUY
$11.79 - $15.97 $120,458 - $163,165
10,217 New
10,217 $128 Million
Q1 2020

Jul 12, 2023

BUY
$9.31 - $21.24 $60,775 - $138,654
6,528 New
6,528 $87.7 Million
Q4 2019

Jul 12, 2023

BUY
$13.91 - $21.48 $90,804 - $140,221
6,528 New
6,528 $131 Million
Q3 2019

Jul 12, 2023

BUY
$15.84 - $30.01 $103,403 - $195,905
6,528 New
6,528 $104 Million
Q2 2019

Jul 12, 2023

BUY
$17.38 - $26.88 $113,456 - $175,472
6,528 New
6,528 $175 Million
Q1 2019

Jul 13, 2023

BUY
$9.2 - $21.21 $60,057 - $138,458
6,528 New
6,528 $112 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $329M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.